Free Twice-Weekly Pharma Manufacturing Newsletter Stay current on Biopharma Packing & Security, Supply Chain Software & Systems, and Contract Manufacturing with a twice-weekly update sent straight to your Inbox. Join more than 30,000 pharma professionals who subscribe to FiercePharmaManufacturing for FREE!
Regeneron ($REGN) has resolved concerns raised by a heritage group about traffic that will be generated by its new drug plant in Limerick, Ireland, the Limerick Leader reports. The Tarrytown, NY-based company now can proceed with its €220 million ($303 million) plans to revamp a former Dell plant there for production of drugs currently in the Eylea maker's pipeline. The drugmaker is working out sustainable transportation solutions to minimize car use for the 300 workers it expects to hire. Story | More
| Wednesday, July 22nd | 11am ET / 8am PT | Sponsored by: UPS
Biopharma companies can never eliminate the risk of supply chain disruption, but they can prevent some problems and prepare themselves for others. Knowing every company in the supply chain--from tier one down--and having contingency plans in place are essential steps to foreseeing and responding to disruptions. Maps of supply chain risks give companies this knowledge. Register Now!
FiercePharmaManufacturing provides must-know news and insight on the hardware and software tools used to automate pharmaceutical manufacturing. Click here to get your free twice weekly email briefing today!